American Century Companies
HRMY icon

American Century Companies’s Harmony Biosciences HRMY Stock Holding History

American Century Companies’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$59M Buy
2,105,179
+263,507
+14% +$8.64M 0.03% 674
2025
Q4 		$68.9M Buy
1,841,672
+172,107
+10% +$5.66M 0.03% 574
2025
Q3 		$46M Buy
1,669,565
+168,145
+11% +$5.79M 0.02% 744
2025
Q2 		$47.4M Buy
1,501,420
+212,633
+16% +$6.84M 0.03% 699
2025
Q1 		$42.8M Buy
1,288,787
+186,183
+17% +$6.67M 0.03% 689
2024
Q4 		$37.9M Buy
1,102,604
+246,140
+29% +$8.46M 0.02% 745
2024
Q3 		$34.3M Buy
856,464
+174,928
+26% +$6.14M 0.02% 779
2024
Q2 		$20.6M Buy
681,536
+238,140
+54% +$7.16M 0.01% 949
2024
Q1 		$14.9M Buy
443,396
+236,977
+115% +$7.61M 0.01% 1042
2023
Q4 		$6.67M Buy
206,419
+810
+0.4% +$22.6K ﹤0.01% 1303
2023
Q3 		$6.74M Sell
205,609
-267,431
-57% -$9.28M 0.01% 1223
2023
Q2 		$16.6M Sell
473,040
-141,801
-23% -$4.9M 0.01% 842
2023
Q1 		$20.1M Sell
614,841
-38,441
-6% -$1.75M 0.02% 748
2022
Q4 		$36M Sell
653,282
-60,583
-8% -$3.33M 0.03% 517
2022
Q3 		$31.6M Buy
713,865
+57,919
+9% +$2.83M 0.03% 512
2022
Q2 		$32M Buy
655,946
+89,638
+16% +$4.04M 0.03% 528
2022
Q1 		$27.6M Buy
566,308
+90,484
+19% +$3.69M 0.02% 612
2021
Q4 		$20.3M Buy
475,824
+287,013
+152% +$11.4M 0.01% 699
2021
Q3 		$7.24M Buy
188,811
+70
+0% +$2.25K 0.01% 926
2021
Q2 		$5.33M Buy
188,741
+37,650
+25% +$1.13M ﹤0.01% 975
2021
Q1 		$4.99M Buy
151,091
+32,542
+27% +$1.14M ﹤0.01% 940
2020
Q4 		$4.29M Buy
118,549
+17,337
+17% +$700K ﹤0.01% 909
2020
Q3 		$3.43M Buy
+101,212
New +$3.69M ﹤0.01% 855

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

American Century Companies's HRMY Position: Q1 2026 in Review

American Century Companies increased its Harmony Biosciences (HRMY) stake by 14% in Q1 2026, buying an estimated $8.64M and bringing the position to 2,105,179 shares worth $59M. The position accounts for 0.03% of the portfolio, ranked #674.

American Century Companies first reported a position in HRMY in Q3 2020 and has held it in 23 quarters since. The position peaked at $68.9M in Q4 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • American Century Companies held 2,105,179 shares of Harmony Biosciences worth $59M as of Q1 2026.
  • American Century Companies bought 263,507 Harmony Biosciences shares in Q1 2026, an estimated $8.64M.
  • Harmony Biosciences made up 0.03% of American Century Companies's portfolio in Q1 2026, its #674 holding.
  • American Century Companies first reported a position in Harmony Biosciences in Q3 2020 and has held it in 23 quarters since.
  • American Century Companies's Harmony Biosciences position peaked at $68.9M in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.